Envoy Medical, Inc. (COCH) income statement
COCHNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCHW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$6.73−0.14 (-2.04%)
Close on Nov 18, 2026Market cap $519.52MP/E –Yield –
Envoy Medical, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- -385.5%
- Operating margin
- -11411.1%
- Net margin
- -11304.8%
- Return on equity, FY2025
- 153.3%
Financial strength
- Current ratio
- 1.73
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 155.8%
Valuation
- P/E ratio
- –
- Price to sales
- 2509.76
- Price to book
- 157.29
- Dividend yield
- –
See a number that looks wrong?